US5954706A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Drug delivery
Assignee: Boston Scientific Corp
•
Filing: 1995-06-07
•
Granted: 1999-09-21
•
Expires: 2015-06-07
Abstract
Abstract The invention features a catheter and methods for delivering drug to tissue at a desired location of the wall of a body lumen. The catheter is constructed for insertion in a body lumen and has a catheter shaft and an expandable portion mounted on the catheter shaft. The expandable portion is expandable to a controlled pressure to fill the cross-section of the body lumen and press against the wall of the body lumen. In one embodiment, at least a portion of the exterior surface of the expandable portion is defined by a coating of a tenaciously adhered swellable hydrogel polymer. Incorporated in the hydrogel polymer is an aqueous solution of a preselected drug to be delivered to the tissue or plaque. The hydrogel polymer and drug are selected to allow rapid release of a desired dosage of the drug from the hydrogel polymer coating during compression of the hydrogel polymer coating against the wall of the lumen when the expandable portion is expanded. In other embodiments the polymer is released from the expandable portion in response to pressure, to coat the wall of the body lumen.
Inventors
- 👤 Ronald A. Sahatjian
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 12:20
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/10; A61M25/104; A61F; A61F2/00; A61F2/82; A61F2/86; A61F2/90; A61K; A61K38/00; A61K38/16; A61K38/43; A61K38/46; A61K38/48; A61K38/49; A61K48/00; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61L; A61L29/00; A61L29/08; A61L29/085; A61L29/14; A61L29/145; A61L29/16; A61L31/00; A61L31/08; A61L31/10; A61L31/14; A61L31/145; A61L31/16; A61L33/00; A61L33/0005; A61L33/0011; A61L33/0023; A61L33/0029; A61M16/00; A61M16/04; A61M16/0475; A61M16/0477; A61M16/0481; A61M25/0043; A61M25/0045; A61F2230/00; A61F2230/0002; A61F2230/0004; A61F2230/0013; A61F2250/00; A61F2250/0058; A61F2250/0067; A61L2300/00; A61L2300/20; A61L2300/252; A61L2300/256; A61L2300/258; A61L2300/40; A61L2300/416; A61L2300/42; A61L2300/45; A61L2300/60; A61L2300/602; A61L2300/606; A61L2300/62; A61L2300/622; A61M2025/0046; A61M2025/0057; A61M25/01; A61M25/09; A61M2025/09175; A61M2025/09183; A61M2025/1043; A61M2025/105; A61M2025/1086; A61M2205/00; A61M2205/02; A61M2205/0266
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
172 words
A method for rapidly delivering a drug into a tissue or occlusive formation at a desired location of a body lumen, comprising: providing a catheter having a catheter shaft constructed for delivery to said tissue or occlusive formation, and an expandable portion mounted on said catheter shaft, said expandable portion being expandable in response to controlled inflation pressure, the expandable portion being characterized by a coating of a tenaciously adhered swellable hydrogel polymer having said drug incorporated therein, said coating, when swelled, being responsive to compressive pressure elevated above said inflation pressure, to reduce the coating thickness and forcing said drug into said tissue or occlusive formation, preparing said expandable portion by introducing said drug to said coating, positioning said expandable portion in said body lumen at the point of desired drug application, expanding said expandable portion against said tissue or occlusive formation to cause delivery of said drug to said tissue or occlusive formation in about thirty minutes or less, deflating said expandable portion, and removing said catheter from said body.
Claim 2
Independent Claim
172 words
A method for rapidly delivering a drug into a tissue or occlusive formation at a desired location of a body lumen, comprising: providing a catheter having a catheter shaft constructed for delivery to said tissue or occlusive formation, and an expandable portion mounted on said catheter shaft, said expandable portion being expandable in response to controlled inflation pressure, the expandable portion being characterized by a coating of a tenaciously adhered swellable hydrogel polymer having said drug incorporated therein, said coating, when swelled, being responsive to compressive pressure elevated above said inflation pressure, to reduce the coating thickness and forcing said drug into said tissue or occlusive formation, preparing said expandable portion by introducing said drug to said coating, positioning said expandable portion in said body lumen at the point of desired drug application, expanding said expandable portion against said tissue or occlusive formation to cause delivery of said drug to said tissue or occlusive formation in about thirty minutes or less, deflating said expandable portion, and removing said catheter from said body.
Claim 3
Dependent Claim
13 words
The method of claim 1, further comprising introducing said catheter to an artery.
Claim 4
Dependent Claim
27 words
The method of claim 1 or 2, wherein said expandable portion is adapted for application of heat to said polymer material to control the rate of administration.
Claim 5
Dependent Claim
19 words
The method of claim 1, wherein said expandable portion includes a stent, placeable in said lumen by expansion thereof.
Claim 6
Dependent Claim
44 words
The method of claim 4, including a binding of said drug and said hydrogel polymer in a coating upon said stent for slow time release of drug remaining in said hydrogel polymer on said stent after compression of said hydrogel polymer by said expansion.
Claim 7
Dependent Claim
22 words
The method of claim 4, wherein said stent is balloon-expandable stent and said expandable portion is a stent positioned about said balloon.
Claim 8
Dependent Claim
20 words
The method of claim 6, wherein said stent and balloon both include said swellable hydrogel polymer coating incorporating said drug.
Claim 9
Dependent Claim
44 words
The method of claim 1, further comprising positioning said expandable portion at a point of occlusion in a body lumen and expanding said expandable portion at pressures sufficient to simultaneously dilate said lumen and deliver said drug by compression of said hydrogel polymer coating.
Claim 10
Dependent Claim
25 words
The method of claim 1, wherein said expandable portion is an inflatable balloon expandable to pressures in the range of about 1 to 20 atmospheres.
Claim 11
Dependent Claim
18 words
The method of claim 9, further comprising delivering about 20% or more of said drug during said compression.
Claim 12
Dependent Claim
16 words
The method of claim 1, wherein said drug is delivered in about ten minutes or less.
Claim 13
Dependent Claim
31 words
The method of claim 1, wherein said hydrogel polymer is selected from the group consisting of polycarboxylic acids, cellulosic polymers, gelatin polyvinylpyrrolidone, maleic anhydride polymers, polamides, polyvinyl alcohols, and polyethylene oxides.
Claim 14
Dependent Claim
12 words
The method of claim 12 wherein said hydrogel polymer is polyacrylic acid.
Claim 15
Independent Claim
18 words
The method of any one of claims 1, 2 or 13 wherein said drug is a monoclonal antibody.
Claim 16
Dependent Claim
16 words
The method of claim 1, wherein said drug is delivered in about fifteen minutes or less.
Claim 17
Dependent Claim
16 words
The method of claim 1, wherein said drug is delivered in about one to ten minutes.
Claim 18
Dependent Claim
16 words
The method of claim 16, wherein said drug is delivered in about one to five minutes.
Claim 19
Dependent Claim
10 words
The method of claim 1 wherein said drug is heparin.
References Cited (Backward Citations)
DE380205C
Cited
US3699956A
Cited
US4026296A
Cited
JPS536430A
Cited
JPS5435036A
Cited
US4299226A
Cited
US4481323A
Cited
US4364392A
Cited
US4330497A
Cited
US4448195A
Cited
GB2112646A
Cited
US4515593A
Cited
US4423725A
Cited
US4769013A
Cited
SU1069826A1
Cited
US4820270A
Cited
US4603152A
Cited
US4693243A
Cited
US4714460A
Cited
US4592340A
Cited
US4589873A
Cited
EP0166998B1
Cited
US4876126A
Cited
US4732930A
Cited
US4832688A
Cited
US4784647A
Cited
US4923450A
Cited
US4983166A
Cited
US4950256A
Cited
EP0372088A1
Cited
WO1989012478A1
Cited
US5232444A
Cited
US4909258A
Cited
US5213580A
Cited
US5163906A
Cited
EP0379156A2
Cited
US5091205A
Cited
US5021044A
Cited
US5047045A
Cited
US5041100A
Cited
US4994033A
Cited
EP0399712A1
Cited
US5026607A
Cited
US4993412A
Cited
WO1991005816A1
Cited
WO1991008790A1
Cited
US5135516A
Cited
US5049132A
Cited
US5234456A
Cited
EP0441516A2
Cited
US5120322A
Cited
US5180366A
Cited
WO1992011895A1
Cited
WO1992011896A1
Cited
US5304121A
Cited
US5102402A
Cited
WO1992013566A1
Cited
WO1992015282A2
Cited
US5213576A
Cited
WO1993011751A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-09-20 | 2003-03-22 | 2003-09-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-09-20 | 2007-03-22 | 2007-09-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-09-20 | 2011-03-22 | 2011-09-21 | $7700.00 | Window Closed / Lapsed |